1. Brotman, R. K., Muzekari, L. H., Shanken, Phyllis, M.: Butaperazine in chronic schizophrenic patients: A double-blind study. Curr. ther. Res. 11, 5?8 (1969).
2. Carscallen, H. B., Rockman, H., Lovegrove, T. D.: High dosage trifluoperazine in schizophrenia. Canad. Psychiat. Ass. J. 13, 459?461 (1968).
3. Clark, M. L., Ramsey, H. R., Ragland, R. E., Rahhal, D. K., Serafetinides, E. A., Costiloe, J. P.: Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships. Psychopharmacologia (Berl.) 18, 260?270 (1970).
4. Cole, J. O., Davis, J. M.: Clinical efficacy of the phenothiazines as antipsychotic drugs. In: Psychopharmacology: A review of progress, pp. 1057?1063. Ed. by D. H. Efron. Washington: U.S. Gov. Printing Office 1968.
5. Curry, S. H., Davis, J. M., Jankowsky, D. S., Marshall, J. H. L.: Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch. gen. Psychiat. 22, 209?214 (1970).